Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Ryan M. Schneider is Director at Elevance Health. OQRO lists 1 transaction filed with the SEC under this name, the latest on May 15, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
Ryan M. Schneider bought shares on the open market in 2021, and has not bought since 2021 across 2 companies. Sales in 5 of the 18 years since 2009.
Ryan M. Schneider reported 2 open-market purchases and 34 sales since 2009; purchases in 2021.
| Year | Bought | Sold |
|---|---|---|
| 2021 | $1M2×2 trades | — |
| 2015 | — | $15.2M9×9 trades |
| 2014 | — | $5.72M2×2 trades |
| 2013 | — | $7.9M2×2 trades |
| 2010 | — | $4.11M10×10 trades |
| 2009 | — | $1.77M11×11 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
May 13, 2026563disclosed May 15
DetailsOfficial recordAs of the latest filing on , Ryan M. Schneider reported holding 7,163 shares of Elevance Health (ELV), worth about $2.83M at the last close of $394 (Nov 20, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Elevance Health ELV | 7,163 | 7,163 direct | $394 | $2.83M | May 13, 2026 |
Is this Ryan M. Schneider’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Ryan M. Schneider reported 0 open-market purchases and 34 sales here, 2009 to 2015.
Ryan M. Schneider reported 2 open-market purchases and 0 sales here, 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated May 13, 2026, Ryan M. Schneider reported holding 7,163 shares of Elevance Health (ELV). At the last close of $394 on Nov 20, 2026, that is about $2.83M. This is the stake disclosed in filings, not a net worth.
No public filing gives Ryan M. Schneider's net worth. What SEC Form 4 shows is the stock stake: 7,163 shares of Elevance Health (ELV), about $2.83M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Ryan M. Schneider bought shares on the open market in 2021, and has not bought since 2021 across 2 companies. Sales in 5 of the 18 years since 2009.
In SEC filings since 2009: the latest open-market purchase is from 2021; the latest open-market sale is from 2015.
2 companies: Elevance Health (ELV, 2021), Capital One (COF, 2009–2015).